Drugs / AdiaVita
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07622316 | Jun → Dec 2026 expected | autism | Greater Atlanta Integrative Pediatrics | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AdiaVita | “This clinical research study evaluates the safety and preliminary effects of AdiaVita (umbilical cord blood-derived stem cells and exosomes) combined with glutathione versus...” NCT07622316 ↗ |
| Modality | Cell therapy | “umbilical cord blood-derived stem cell and exosome product” NCT07622316 ↗ |
| Route | Intravenous | “monthly intravenous infusions of AdiaVita” NCT07622316 ↗ |